BDX · Becton Dickinson & Co
$166.33
+7.41 (+4.66%)
At close · Jul 28
Market Cap
$43.79B
Shares
275.54M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Michael D. Garrison | Executive Vice President and President of the Medical Essentials and BioPharma Systems segments | Retired | 2026-07-22 |
Key facts
CIK
10795
CUSIP
075887109
13F (30d)
495 filings
451 filers
Visit website
Investor relations